The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Oxervate

20 microgram(s)/millilitre Eye drops, solution

Dompe farmaceutici SpAEU/1/17/1197/01

Main Information

Trade NameOxervate
Active SubstancesRecombinant human nerve growth factor (rhngf)
Strength20 microgram(s)/millilitre
Dosage FormEye drops, solution
Licence HolderDompe farmaceutici SpA
Licence NumberEU/1/17/1197/01

Group Information

ATC CodeS01 OPHTHALMOLOGICALS

Status

Authorised/WithdrawnAuthorised
Licence Issued06/07/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back